Acupuncture for Chronic Pain-Related Depression: A Systematic Review and Meta-Analysis
You et al. · Pain Research and Management · 2021
Evidence Level
MODERATEOBJECTIVE
To assess the efficacy and safety of acupuncture in treating chronic pain-related depression
WHO
636 patients diagnosed with concomitant depression and chronic pain
DURATION
Studies ranged from 4 weeks to 2 months
POINTS
Manual acupuncture and electroacupuncture; specific points not detailed
🔬 Study Design
Acupuncture alone
n=130
manual acupuncture or electroacupuncture
Acupuncture + medication
n=186
acupuncture combined with antidepressants
Conventional medication
n=320
antidepressants and analgesics
📊 Results in numbers
Reduction in HAMD (acupuncture+medication vs medication)
Reduction in VAS (acupuncture+medication vs medication)
Reduction in adverse events (acupuncture vs medication)
Efficacy of acupuncture alone vs medication (HAMD)
📊 Outcome Comparison
HAMD Scale (depression)
VAS Scale (pain)
This study shows that acupuncture is a safe option for treating depression associated with chronic pain. When used together with antidepressants, acupuncture provides better outcomes for both depression and pain. Acupuncture alone has fewer side effects than conventional medications.
Article summary
Plain-language narrative summary
Chronic pain and depression are two conditions that often go hand in hand, creating a complex cycle that affects millions of people around the world. When a person lives with constant pain for more than three months, this can trigger feelings of sadness, hopelessness, and depression. Conversely, depression can intensify the perception of pain, making suffering even greater. This phenomenon, known as chronic pain-related depression, poses a significant challenge for patients and healthcare professionals, since conventional drug treatments often have important limitations, such as significant side effects and high rates of treatment discontinuation.
The aim of this scientific study was to investigate whether acupuncture may be an effective and safe alternative for the treatment of chronic pain-related depression. The researchers conducted a systematic review and meta-analysis, a type of research that gathers and statistically analyzes data from multiple studies on the same topic, providing more robust evidence. Eight randomized controlled clinical trials involving a total of 636 participants were analyzed, all conducted in China. The studies compared different approaches: some compared acupuncture alone with medication, while others evaluated the combination of acupuncture with medication versus medication alone.
To measure outcomes, the researchers used standardized scales that assess depression and pain intensity, in addition to recording any adverse effects of the treatments.
The results of the study revealed interesting and promising findings on the role of acupuncture in treating this complex condition. When acupuncture was used alone compared with traditional medications, both treatments showed similar efficacy in reducing depressive symptoms and relieving pain. However, acupuncture demonstrated a significantly superior safety profile, with a much lower incidence of adverse effects compared with medications. Even more encouraging was the finding that when acupuncture was combined with medication, this integrated approach proved more effective than the use of medication alone, providing greater relief of both depressive symptoms and chronic pain while maintaining a favorable safety profile.
The implications of these findings are substantial for patients suffering from chronic pain accompanied by depression. Acupuncture emerges as a valuable therapeutic option that can be considered both as an alternative and as a complement to conventional treatments. For patients who experience significant side effects with antidepressants or analgesics, acupuncture offers a gentler approach with a lower risk of adverse reactions. Furthermore, the possibility of combining acupuncture with medication may allow the use of lower drug doses, potentially reducing side effects while maintaining or even improving therapeutic efficacy.
For healthcare professionals, these results suggest that acupuncture should be considered as part of an integrated approach to managing chronic pain with depression, particularly in cases where conventional treatments do not provide adequate relief or cause unacceptable adverse effects.
It is important to acknowledge that this study has some limitations that should be considered when interpreting the results. The number of included studies was relatively small, and many had limited participant samples, which can affect the precision of the conclusions. In addition, the methodological quality of the studies analyzed was not uniform, with some showing deficiencies in experimental design, such as a lack of details on randomization and absence of adequate blinding procedures — although this is partially understandable given the difficulty of "blinding" acupuncture treatments. All studies were conducted in China, which may limit the generalizability of the results to other populations and healthcare systems.
Despite these limitations, the findings are encouraging and suggest that acupuncture represents a promising therapeutic modality for the treatment of chronic pain-related depression. Future studies with larger samples, more rigorous methodology, and more diverse populations will be needed to confirm these results and establish more precise treatment protocols, but the current data already offer a solid basis for considering acupuncture as part of the therapeutic armamentarium available for this challenging condition.
Strengths
- 1First meta-analysis to separate acupuncture alone from combination therapy
- 2Evaluated both depressive symptoms and pain
- 3Analyzed safety with adverse events
- 4Included both manual acupuncture and electroacupuncture
Limitations
- 1Low methodological quality of included studies
- 2All studies conducted in China — possible publication bias
- 3High heterogeneity across studies
- 4Small number of included studies (8 RCTs)
- 5Blinding not feasible given the nature of acupuncture
Expert Commentary
Prof. Dr. Hong Jin Pai
PhD in Sciences, University of São Paulo
▸ Clinical Relevance
The comorbidity of chronic pain and depression is one of the most frustrating clinical situations we face on a daily basis — the neurobiological mechanisms feed back on each other, and treating only one dimension frequently results in a partial response and early recurrences. This work by You et al. provides systematized evidence for a question that any physician managing chronic pain has already asked: does acupuncture have a place in this scenario? The answer, at least for the strategy combined with antidepressants, is affirmative — with measurable gains on the HAMD and VAS compared with pharmacotherapy alone. The favorable safety profile (adverse-event OR of 0.03 versus conventional medication) is especially relevant for older, polymedicated patients or those with gastrointestinal intolerance to antidepressants and analgesics, populations in which acupuncture can make a reduction in pharmacologic burden feasible without sacrificing efficacy.
▸ Notable Findings
The methodological decision to separate acupuncture as monotherapy from acupuncture as combination therapy reveals a finding with real clinical weight: acupuncture alone did not outperform medication on depressive symptoms, while the combination produced a statistically significant difference of -2.95 points on the HAMD and -1.06 on the VAS versus pharmacotherapy alone. This differential response pattern suggests that acupuncture acts through pathways complementary to those of antidepressants — and not as a direct substitute — which makes sense in light of the neurobiology of pain-depression, which intricately involves descending modulation circuits, the HPA axis, and serotonin. Equally notable is the asymmetry in the safety profile: acupuncture as monotherapy showed a dramatically lower rate of adverse events than medication, a relevant finding when discussing long-term adherence in patients with chronicity.
▸ From My Experience
In my practice at the Pain Center of HC-FMUSP, the combination of acupuncture and antidepressants — especially dual-acting agents such as duloxetine — has become one of the most-used strategies in managing patients with chronic musculoskeletal pain and concomitant depression. I usually observe the first analgesic responses in three to four sessions, but mood improvement tends to appear between the fifth and eighth sessions, which guides the conversation with the patient about realistic expectations. In general, we work with cycles of ten to twelve acute sessions, followed by biweekly or monthly maintenance. The patient profile that benefits most, in my experience, is the one with fibromyalgia or chronic low back pain who has already tried two or more antidepressants with compromised adherence due to side effects. In these cases, adding acupuncture allows the medication dose to be reduced without loss of clinical efficacy — something I observe regularly and that the data from this meta-analysis consistently corroborate.
Full original article
Read the full scientific study
Pain Research and Management · 2021
DOI: 10.1155/2021/6617075
Access original articleScientific Review

Marcus Yu Bin Pai, MD, PhD
CRM-SP: 158074 | RQE: 65523 · 65524 · 655241
PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.
Learn more about the author →Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.
Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.
Related articles
Based on this article’s categories